Murray Kwon, MD
Surgery · Los Angeles, CANPI 1841482981
Payments from drug & device makers
Across 235 payments — averaging $113.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$20K
- Davol Inc.$3K
- Medtronic$1K
- Abiomed$656
- Johnson & Johnson$605
- Bolton Medical Inc$159
- plus $315 from 5 others
Across 1 payment — averaging $950.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- US Endoscopy$950
What the payments were for
- Consulting fees$11,90945%
- Speaking & faculty fees$3,45013%
- Travel & lodging$1,8647%
- Food & beverage$9,42735%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 197 | $20,250 |
| Davol Inc. | 4 | $3,382 |
| Medtronic(2 entities) | 17 | $1,283 |
| Abiomed | 5 | $656 |
| Johnson & Johnson | 1 | $605 |
| Bolton Medical Inc | 1 | $159 |
| Boston Scientific | 2 | $141 |
| Abbott | 3 | $71 |
| Atricure, Inc. | 2 | $45 |
| Baxter Healthcare | 2 | $44 |
| LSI Solutions Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROLENE$1,210
- MITRIS RESILIA Mitral Valve$750
- COREVALVE EVOLUT R$637
- Impella$450
- Edwards SAPIEN 3 Transcatheter Heart Valve$309
- SAPIEN 3 Ultra RESILIA$259
- HeartWare HVAD$251
- INSPIRIS RESILIA aortic valve$230
- TREO ABDOMINAL STENT-GRAFT SYSTEM$159
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$135
- GENERAL - STRUCTURAL HEART$123
How this compares
$26,650 in reported general payments places this provider in the 85th percentile of 2,363 surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgery in Los Angeles
- John LiphamLos Angeles$991K
- Caitlin HoughtonLos Angeles$643K
- Nikolai BildzukewiczLos Angeles$348K
- Miguel BurchLos Angeles$290K
- Peyman BenharashLos Angeles$218K
- Raul RosenthalLos Angeles$210K
- Timothy DonahueLos Angeles$200K
- Timothy ChuterSan Francisco$8.9M
- Peter StockSan Francisco$6.5M
- Santiago HorganSan Diego$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.